Trial Profile
Randomized, DB, Parallel Group, MC Study to Evaluate the Efficacy and Safety of Four Doses of Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract (Depigoid Birch) in Patients With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis; Hypersensitivity; Seasonal allergic rhinitis
- Focus Therapeutic Use
- 07 Jun 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2010 Status changed from recruiting to active, no longer recruiting according to ClinicalTrials.gov.